Gesamtlänge aller Episoden: 3 days 2 hours 4 minutes
Amarjot Kaur discusses the new mentoring program of the ASA Biopharmaceutical Section.
A recording of A Conversation with Bob O'Neill which took place during a recent ASA Boston Chapter meeting. Dr. O’Neill discusses aspects of the past, present, and future of regulatory statistics in an interview format with Dr. Scott Evans. Topics include: Dr. O’Neill’s view of challenging issues of the future, key challenges for the FDA during his tenure, and training in regulatory statistics and decision making.
Ted Lystig discusses some of the unique challenges present in the development of medical devices, and the recent formation of the new ASA Section on Medical Devices and Diagnostics.
Cristiana and Shiowjen discuss the 2014 ASA Biopharm Section FDA-Industry Statistics Workshop.
Ivan Chan discusses Biopharm Section activities at the 2014 Joint Statistical Meetings in Boston.
The past, current and chair-elect of PSI (Katherine Hutchinson, Robert Cuffe and Mark Morris, respectively) describe the history of the organization and discuss differences in the regulatory experience between the U.S. and E.U.
Biopharmaceutical Section Chair Matilde Sanchez-Kam talks about the challenges of a small pharmaceutical company, volunteering with the section, and building collaborations with other statistics organizations.
Karen Price talks about all things Bayesian in the world of pharmaceutical development: methodology, the DIA Bayesian Scientific Working Group, and the special Bayesian issue of Pharmaceutical Statistics.
Olga Marchenko from Quintiles gives a brief overview of the upcoming Trends and Innovations in Clinical Trial Statistics Conference to take place April 21-23 in Research Triangle Park, North Carolina.